Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide

Ann Hematol. 2012 May;91(5):797-799. doi: 10.1007/s00277-011-1322-0. Epub 2011 Sep 8.

Authors

Joyeeta Bhattacharyya¹, Keichiro Mihara², Yoshihiro Takihara³, Akiro Kimura¹

Affiliations

¹ Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
² Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan. [email protected].
³ Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.

PMID: 21901341
DOI: 10.1007/s00277-011-1322-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anemia, Hemolytic, Autoimmune / complications*
Anemia, Hemolytic, Autoimmune / drug therapy*
Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cryoglobulinemia / complications*
Cryoglobulinemia / drug therapy*
Cyclophosphamide / administration & dosage
Female
Humans
Immunoglobulin M / blood
Livedo Reticularis / diagnosis
Middle Aged
Monoclonal Gammopathy of Undetermined Significance / complications*
Monoclonal Gammopathy of Undetermined Significance / diagnosis
Monoclonal Gammopathy of Undetermined Significance / drug therapy*
Rituximab
Vidarabine / administration & dosage
Vidarabine / analogs & derivatives

Substances

Antibodies, Monoclonal, Murine-Derived
Immunoglobulin M
Rituximab
Cyclophosphamide
Vidarabine
fludarabine